Integra LifeSciences (IART) Competitors

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends.

Which has preferable valuation & earnings, ITGR or IART?

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.71B	2.68	$90.65M	$3.24	42.20
Integra LifeSciences	$1.56B	1.14	$67.74M	-$0.09	-255.89

Does the media refer more to ITGR or IART?

In the previous week, Integer had 5 more articles in the media than Integra LifeSciences. MarketBeat recorded 8 mentions for Integer and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.12 beat Integer's score of 0.94 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is ITGR or IART more profitable?

Integer has a net margin of 6.70% compared to Integra LifeSciences' net margin of -0.42%. Integra LifeSciences' return on equity of 12.35% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.70%	11.63%	5.86%
Integra LifeSciences	-0.42%	12.35%	4.82%

Does the MarketBeat Community favor ITGR or IART?

Integra LifeSciences received 49 more outperform votes than Integer when rated by MarketBeat users. However, 63.92% of users gave Integer an outperform vote while only 56.83% of users gave Integra LifeSciences an outperform vote.

Company	Underperform	Outperform
Integer	Outperform Votes 388 63.92%	Underperform Votes 219 36.08%
Integra LifeSciences	Outperform Votes 437 56.83%	Underperform Votes 332 43.17%

Do institutionals & insiders have more ownership in ITGR or IART?

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has more volatility and risk, ITGR or IART?

Integer has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500.

Do analysts recommend ITGR or IART?

Integer currently has a consensus target price of $145.44, indicating a potential upside of 6.38%. Integra LifeSciences has a consensus target price of $23.00, indicating a potential downside of 0.13%. Given Integer's stronger consensus rating and higher possible upside, equities research analysts plainly believe Integer is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Integra LifeSciences	3 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Summary

Integer beats Integra LifeSciences on 13 of the 18 factors compared between the two stocks.